 1:10) and they were not protected from lethal intraperitoneal or lethal ocular challenge with HSV-1. Thus, when used as a vaccine in the mouse model, gL, similar to our findings with HSV-1 gH, but unlike our results with the other 6 HSV-1 glycoproteins that we have expressed in this baculovirus system, did not provide any protection against HSV-1 challenge.  PMID: 7998829  [PubMed - indexed for MEDLINE]   2813. Acta Neurochir Suppl (Wien). 1994;60:335-7.